Amantadine in Treatment of Dysthymia—The Pilot Case Series Study

M Krzystanek, E Martyniak, A Pałasz, K Skałacka… - Pharmaceuticals, 2023 - mdpi.com
Dysthymia is a common chronic mood disorder in which isolated symptoms of depression
persist for at least 2 years. Despite the many medications recommended for the treatment of …

[PDF][PDF] Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes

JH Kocsis, S Zisook, J Davidson… - American Journal of …, 1997 - researchgate.net
Objective: The purpose of this study was to determine the effects of antidepressant
pharmacotherapy on mood symptoms and psychosocial outcomes in dysthymia. Method: In …

The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis

MS de Lima, M Hotoph, S Wessely - Psychological Medicine, 1999 - cambridge.org
Background. Dysthymia is a common mental disorder, associated with considerable
disability and high co-morbidity. This review assessed the role of pharmacological treatment …

Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence

MS De Lima, M Hotopf - Drug safety, 2003 - Springer
Background: Dysthymia is a prevalent form of subthreshold depressive disorder, associated
with considerable disability and high co-morbidity. This paper systematically appraises the …

Pharmacotherapy of dysthymia: review and new findings

M Versiani, AE Nardi, I Figueira - European psychiatry, 1998 - Elsevier
Open trials with tricyclics, classical monoamine oxidase inhibitors (MAOIs) or lithium in
dysthymia yielded a response rate in 45% of subjects. A long-term treatment of dysthymia …

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia

ME Thase, M Fava, U Halbreich… - Archives of General …, 1996 - jamanetwork.com
Background: Despite the high prevalence of dysthymia and its associated morbidity, few
controlled trials have evaluated the efficacy of antidepressant medication for this disorder. A …

Dysthymia: options in pharmacotherapy

D Baldwin, S Rudge, S Thomas - CNS drugs, 1995 - Springer
Dysthymic disorder (dysthymia) was introduced into the group of affective or mood disorders
with the publication of the DSM-III in 1980, Although little was known of dysthymia at the time …

Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder.

D Bakish, A Ravindran, C Hooper… - Psychopharmacology …, 1994 - europepmc.org
In spite of its significant morbidity, dysthymic disorder has been under-researched, therefore
effective treatment options are limited. This article presents data suggesting that dysthymia …

The treatment of dysthymia with sertraline: a double-blind placebo-controlled trial in dysthymic outpatients without major depression

JD Guelfi, RL Wiseman - European Neuropsychopharmacology, 1995 - infona.pl
Dysthymia is a chronic and persistent depressive disorder frequently accompanied by major
depression or other psychiatric disorders. Effective antidepressant treatment of the major …

Acute and long-term pharmacotherapeutic strategies in pure dysthymia: efficacy of sertraline and imipramine

J Kocsis - European Neuropsychopharmacology, 1995 - infona.pl
An essential feature of dysthymic disorder, as defined in DSM-IV, is a chronically depressed
mood of at least 2 years' duration. Prevalence studies suggest this disorder has been …